<DOC>
	<DOCNO>NCT00376571</DOCNO>
	<brief_summary>How use drug elute stent ( DES ) bifurcation lesion . A strategy routine stenting main vessel side branch versus strategy routine main vessel stenting optional treatment side branch . A randomized Nordic multicenter study include 400 patient angina pectoris clinical angiographic follow-up .</brief_summary>
	<brief_title>Nordic Bifurcation Study . How Use Drug Eluting Stents ( DES ) Bifurcation Lesions ?</brief_title>
	<detailed_description>Design : * Randomized open multicentre trial . Patients : - Number 400 . Inclusion criterion : - Stable unstable AP . - Bifurcation lesion `` LAD/diagonal '' , `` Cx/obtuse marginal '' , `` RCA-PDA/posterolateral branch LM/Cx/LAD right dominant system . - Diameter main vessel visual estimate &gt; 2.5 mm . - Diameter side branch visual estimate &gt; 2.0 mm . - Signed informed consent . Exclusion criterion : - ST-elevation Acute Myocardial infarction ( AMI ) within 24 hour . - Expected survival &gt; 1 year . - S-creatinine &gt; 200 Umol/l . - Allergy Aspirin , Clopidogrel Ticlopidine . - Allergy sirolimus/paclitaxel . - Left main bifurcation non-right dominant system . Randomization : * Treatment strategy routine stenting main vessel side branch versus routine main vessel stenting optional treatment side branch . Primary end-point : * Combined end-point cardiac death , myocardial infarction , stent thrombosis TVR 6 month . Secondary end-point : - Clinical 1 MACE ( cardiac death , myocardial infarction , stent thrombosis TVR ) hospital period , 1 8 month . 2 Cardiac death hospital period , 1 , 6 8 month . 3 Myocardial infarction hospital period , 1 , 6 8 month . 4 Stent thrombosis hospital period , 1 , 6 8 month . 5 TVR hospital period , 1 , 6 8 month . 6 Total death hospital period , 1 , 6 8 month . 7 TLR hospital period , 1 , 6 8 month . 8 Myocardial infarction relate index procedure . 9 CCS angina score 6 8 month . - Angiographic 1 . Angiographic restenosis ( &gt; 50 % diameter stenosis ) main vessel occlusion side branch 2 . Late loss main vessel side branch 8 month . 3 . Percentual diameter stenosis main vessel side branch 8 month . 4 . Angiographic restenosis ( &gt; 50 % diameter stenosis ) rate main vessel side branch 8 month . End-point evaluation : Primary secondary end-points assessed independent end-point committee . The end-point committee consist experience interventional cardiologist . Detailed end-point definition : - Q-wave myocardial infarction : Appearance new Q-wave two contiguous lead ECG . - Non-Q-wave myocardial infarction : Infarction , consider present patient clinical , angiographic , electrocardiographic and/or laboratory evidence myocardial necrosis ECG show new Q-waves . - Procedure relate myocardial infarction : A threefold increase CK-MB Troponin-T/I . - Target lesion revascularization : Coronary bypass operation graft PCI index lesion . - Target vessel revascularization : Coronary bypass operation graft PCI index vessel . - Stent thrombosis : Thrombotic occlusion index stent/stents . - Vessel measurement : 1 Proximal reference diameter : Vessel diameter proximal lesion . 2 Distal reference diameter : Vessel diameter distal lesion . 3 Reference diameter : Mean proximal distal vessel diameter . 4 Percentual diameter stenosis : ( Reference diameter - minimal luminal diameter ) /reference diameter percent . - Angiographic restenosis : &gt; 50 % diameter stenosis . Angiographic core lab : The index follow-up angiogram assess blindly QCA core lab . Department Cardiology , Skejby Hospital , DK-8200 Aarhus N , Denmark . * Definition index angiography : The angiography obtain PCI procedure use index angiography . * Definition follow-up angiography : After 8 month conventional diagnostic angiography perform projection use index angiography repeat . Steering committee : The steer committee consist one two investigator center . All steer committee member full access database participate interpretation data . Progress study : The progress study check weekly basis steer committee . They receive evaluate data inclusion rate primary end-point event rate . Further , steer committee receive evaluate weekly safety data rate stent thrombosis two group . Statistics data management : - The statistical analysis perform UNI-C , University Aarhus . - Primary end-point : The composite primary end-point 6 month follow-up analyzed Kaplan-Meier method . Differences event-free survival curve compare use Wilcoxon log-rank test . Two-sided test use p-value consider indicate significance 0.05 . - Secondary end-points parameter : For continuous variable , difference treatment group evaluate analysis variance Wilcoxon 's rank-sum test . For discrete variable , difference express count percentage analyze Fisher 's exact test . Secondary end-points assess 8 month . Two-sided test use p-value consider indicate significance 0.05 . Safety : * For safety reason , stent thrombosis one month monitor continuously . A stent thrombosis rate &gt; 5 % treatment group necessitate premature termination trial . Analysis population : * Results analyze accord intention-to-treat principle , i.e . patient randomize certain group follow assessed irrespectively actual treatment . Protocol violation note responsible center notify . Sample size calculation : * With expect primary end-point event rate 30 % `` stenting main vessel side branch group '' , alpha 5 % power 80 % , reduction primary end-point event rate 15 % `` optional side branch treatment group '' detect 200 patient group . Randomization procedure : - The patient randomized beginning PCI procedure insertion wire balloon . - There block randomization accord centre stratification accord sex , age &gt; 70 year , diabetes , use GPIIb/IIIa blocker +/- angiographic follow-up . - The patient computer randomize 24 hour telephone service . The PARAVOX system use . Monitoring study : Data monitor accord GCP rule independent professional . During trial , monitor regular contact trial site ( ) , include visit ensure trial conduct document properly compliance protocol , GCP applicable regulatory requirement . Publication : * Results publish international cardiovascular journal . Publication author issue decide steer committee basis general involvement study ( core lab . function , end-point committee membership ect . ) number include patient .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<criteria>Stable unstable AP . Bifurcation lesion `` LAD/diagonal '' , `` Cx/obtuse marginal '' , `` RCAPDA/posterolateral branch LM/Cx/LAD right dominant system . Diameter main vessel visual estimate &gt; 2.5 mm . Diameter side branch visual estimate &gt; 2.0 mm . Signed informed consent . STelevation AMI within 24 hour . Expected survival &lt; 1 year . Screatinine &gt; 200 Umol/l . Allergy Aspirin , Clopidogrel Ticlopidine . Allergy sirolimus/paclitaxel . Left main bifurcation nonright dominant system .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>PCI</keyword>
	<keyword>Bifurcation lesion</keyword>
</DOC>